Revvity (NYSE:RVTY – Get Free Report) and Cannlabs (OTCMKTS:CANL – Get Free Report) are both medical companies, but which is the superior investment? Get Revvity alerts:ProfitabilityThis table compares Revvity and Cannlabs’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Revvity 8.44% 7.52% 4.61% Cannlabs N/A N/A N/AInsider & Institutional OwnershipValuation and Earnings86.7% of Revvity shares are owned by institutional investors. Analyst RatingsThis is a summary of recent recommendations for Revvity and Cannlabs, as provided by MarketBeat. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing.